| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2613 |
| Trial ID | NCT04787263 |
| Disease | Diffuse Large B-Cell Lymphoma | Acute Lymphoblastic Leukemia | Primary Mediastinal B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML |
| Year | 2021 |
| Country | Italy |
| Company sponsor | Bambino Gesù Hospital and Research Institute |
| Other ID(s) | CD19-CAR_Lenti |
| Cohort 1 | |||||||||||
|
|||||||||||